Building the European biotherapeutics sector together
France has made biotherapies and bioproduction a strategic priority of France 2030. Therapeutic innovation does not stop at national borders: it is also being developed at the European level through ongoing interactions between research, industry, regulation, and public policy.
The PEPR Biotherapies, in collaboration with the Integrators Network, France Biolead, COMBIO, and the CMAs, are organizing BioSynEurope, a two-day scientific conference dedicated to biotherapies and bioproduction, designed to serve as a bridge between French national initiatives and the strategies led by our European neighbors.
This event will bring together researchers, industry representatives, institutional stakeholders, and sector representatives around a shared goal: to strengthen European collaborations and build a shared ecosystem for the development of biotherapies and their bioproduction.
Objectives of the conference
- Gain a better understanding of existing initiatives in Europe and promote networking among stakeholders
- Initiate a process of building partnerships and identify funding opportunities at the European level
- Share experiences on the regulatory, scientific, and socioeconomic challenges of developing biotherapies, particularly advanced therapy medicinal products
Why participate?
Whether you are a researcher, industry professional, student, or institutional representative, participating in the BioSynEurope conference will give you the opportunity to:
- A clear understanding of national and European trends in the sectori
- Concrete opportunities for networking and partnerships
- Insights into the regulatory framework and its evolution
- Insights into jobs and skills of the future